Glucose-lowering effect of insulin glargine 300 U/ml in Japanese type 2 diabetic patients treated with basal-bolus insulin therapy
Not Applicable
- Conditions
- type 2 diabetes
- Registration Number
- JPRN-UMIN000019352
- Lead Sponsor
- Shiraiwa Medical Clinic
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
- treated with antidiabetic drugs other than insulin - difficulty to perform self-monitoring of blood glucose - severe hepatic, renal and/or cardiac disease - hypersensitivity to insulin glargine 300 U/ml - pregnant or breast-feeding females. - Patients who are judged by the investigator to be inappropriate for this study for any other reason.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Daily profiles of glucose levels after injection of insulin glargine 300 U/ml
- Secondary Outcome Measures
Name Time Method